The proprietor of Wegovy and Ozempic has suffered a major setback, as its extremely anticipated new weight-loss therapy was labelled “out of date” after disappointing medical trials.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
